HRT Financial’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

HRT Financial’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,558	Closed	-$11K	–	3361
2023 Q4	$11K	Buy	+16,558	New	+$9.61K	﹤0.01%	2081
2023 Q2	–	Sell	-2,055	Closed	-$16K	–	3534
2023 Q1	$16K	Buy	2,055 +1,867	+993%	+$24.8K	﹤0.01%	2208
2022 Q4	$2K	Buy	+188	New	+$2.15K	﹤0.01%	2347
2022 Q3	–	Sell	-389	Closed	-$13K	–	3707
2022 Q2	$13K	Buy	+389	New	+$12.1K	﹤0.01%	2649
2022 Q1	–	Sell	-305	Closed	-$12K	–	4072
2021 Q4	$12K	Buy	+305	New	+$19K	﹤0.01%	3009

Other funds holding DMK

CPA

Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return

OPTFSNA

Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

HRT Financial's DMK Position: Q1 2024 in Review

HRT Financial sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 16,558 shares — an estimated $11K sold.

HRT Financial first reported a position in DMK in Q4 2021 and held it in 5 quarters. The position peaked at $16K in Q1 2023. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

HRT Financial reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
HRT Financial sold 16,558 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $11K.
HRT Financial first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2021 and held it in 5 quarters.
HRT Financial's DMK Pharmaceuticals Corporation Common Stock position peaked at $16K in Q1 2023.
3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.